Hariton C - Search Results

1

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.

Escudier B, Choueiri TK, Oudard S, Szczylik C, Négrier S, Ravaud A, Chevreau C, Venner P, Champagne P, Croteau D, Dupont E, Hariton C, Bukowski RM. Escudier B, et al. Among authors: hariton c. J Urol. 2007 Nov;178(5):1901-5. doi: 10.1016/j.juro.2007.07.035. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868728 Clinical Trial.

2

Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels.

Batist G, Patenaude F, Champagne P, Croteau D, Levinton C, Hariton C, Escudier B, Dupont E. Batist G, et al. Among authors: hariton c. Ann Oncol. 2002 Aug;13(8):1259-63. doi: 10.1093/annonc/mdf195. Ann Oncol. 2002. PMID: 12181250 Free article. Clinical Trial.

3

Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.

Latreille J, Batist G, Laberge F, Champagne P, Croteau D, Falardeau P, Levinton C, Hariton C, Evans WK, Dupont E. Latreille J, et al. Among authors: hariton c. Clin Lung Cancer. 2003 Jan;4(4):231-6. doi: 10.3816/clc.2003.n.003. Clin Lung Cancer. 2003. PMID: 14624712

4

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.

Falardeau P, Champagne P, Poyet P, Hariton C, Dupont E. Falardeau P, et al. Among authors: hariton c. Semin Oncol. 2001 Dec;28(6):620-5. doi: 10.1016/s0093-7754(01)90035-1. Semin Oncol. 2001. PMID: 11740820 Review.

5

Recent Developments at DG Competition: 2017/2018.

Amelio A, Buettner T, Hariton C, Koltay G, Papandropoulos P, Sapi G, Valletti T, Zenger H. Amelio A, et al. Among authors: hariton c. Rev Ind Organ. 2018;53(4):653-679. doi: 10.1007/s11151-018-9671-7. Epub 2018 Nov 1. Rev Ind Organ. 2018. PMID: 30546197 Free PMC article.

6

Recent Developments at DG Competition: 2016/2017.

Buehler B, Coublucq D, Hariton C, Langus G, Valletti T. Buehler B, et al. Among authors: hariton c. Rev Ind Organ. 2017;51(4):397-422. doi: 10.1007/s11151-017-9592-x. Epub 2017 Nov 9. Rev Ind Organ. 2017. PMID: 29187775 Free PMC article.

7

Concomitant treatment with a 5-lipoxygenase inhibitor improves the anti-inflammatory effect of the inhibition of nitric oxide synthase during the early phase of endotoxin-induced uveitis in the rabbit.

Bellot JL, Palmero M, Alcoriza N, Blanco A, García-Cabanes C, Hariton C, Orts A. Bellot JL, et al. Among authors: hariton c. Ophthalmic Res. 1997;29(4):227-36. doi: 10.1159/000268017. Ophthalmic Res. 1997. PMID: 9261846

8

Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine.

Percicot CL, Schnell CR, Debon C, Hariton C. Percicot CL, et al. Among authors: hariton c. J Pharmacol Toxicol Methods. 1996 Dec;36(4):223-8. doi: 10.1016/s1056-8719(96)00130-x. J Pharmacol Toxicol Methods. 1996. PMID: 9040114

9

Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit.

Bellot JL, Palmero M, García-Cabanes C, Espí R, Hariton C, Orts A. Bellot JL, et al. Among authors: hariton c. Inflamm Res. 1996 Apr;45(4):203-8. doi: 10.1007/BF02285162. Inflamm Res. 1996. PMID: 8741011

10

Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs.

Khosravi E, Elena PP, Hariton C. Khosravi E, et al. Among authors: hariton c. Inflamm Res. 1995 Jan;44(1):47-54. doi: 10.1007/BF01630487. Inflamm Res. 1995. PMID: 7664029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters